Literature DB >> 33472914

Brain Histopathology of Adult Decedents After Extracorporeal Membrane Oxygenation.

Imad R Khan1, Yang Gu2, Benjamin P George2, Laura Malone2, Kyle S Conway2, Fabienne Francois2, Jack Donlon2, Nadim Quazi2, Ashwin Reddi2, Cheng-Ying Ho2, Daniel L Herr2, Mahlon D Johnson2, Gunjan Y Parikh2.   

Abstract

OBJECTIVE: To test the hypothesis that brain injury is more common and varied in patients receiving extracorporeal membrane oxygenation (ECMO) than radiographically observed, we described neuropathology findings of ECMO decedents and associated clinical factors from 3 institutions.
METHODS: We conducted a retrospective multicenter observational study of brain autopsies from adult ECMO recipients. Pathology findings were examined for correlation with demographics, clinical data, ECMO characteristics, and outcomes.
RESULTS: Forty-three decedents (n = 13 female, median age 47 years) received autopsies after undergoing ECMO for acute respiratory distress syndrome (n = 14), cardiogenic shock (n = 14), and cardiac arrest (n = 15). Median duration of ECMO was 140 hours, most decedents (n = 40) received anticoagulants; 60% (n = 26) underwent venoarterial ECMO, and 40% (n = 17) underwent venovenous ECMO. Neuropathology was found in 35 decedents (81%), including microhemorrhages (37%), macrohemorrhages (35%), infarctions (47%), and hypoxic-ischemic brain injury (n = 17, 40%). Most pathology occurred in frontal neocortices (n = 43 occurrences), basal ganglia (n = 33), and cerebellum (n = 26). Decedents with hemorrhage were older (median age 57 vs 38 years, p = 0.01); those with hypoxic brain injury had higher Sequential Organ Failure Assessment scores (8.0 vs 2.0, p = 0.04); and those with infarction had lower peak Paco2 (53 vs 61 mm Hg, p = 0.04). Six of 9 patients with normal neuroimaging results were found to have pathology on autopsy. The majority underwent withdrawal of life-sustaining therapy (n = 32, 74%), and 2 of 8 patients with normal brain autopsy underwent withdrawal of life-sustaining therapy for suspected neurologic injury.
CONCLUSION: Neuropathological findings after ECMO are common, varied, and associated with various clinical factors. Further study on underlying mechanisms is warranted and may guide ECMO management.
© 2021 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33472914      PMCID: PMC8055323          DOI: 10.1212/WNL.0000000000011525

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

1.  Pituitary necrosis in routine necropsies.

Authors:  A PLAUT
Journal:  Am J Pathol       Date:  1952 Sep-Oct       Impact factor: 4.307

2.  Understanding Characteristics of Acute Brain Injury in Adult Extracorporeal Membrane Oxygenation: An Autopsy Study.

Authors:  Sung-Min Cho; Romergryko G Geocadin; Giorgio Caturegli; Vanessa Chan; Bartholomew White; Jeffrey Dodd-O; Bo Soo Kim; Marc Sussman; Chun Woo Choi; Glenn Whitman; Liam L Chen
Journal:  Crit Care Med       Date:  2020-06       Impact factor: 7.598

3.  Hemolysis and Nonhemorrhagic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Omar Saeed; William A Jakobleff; Stephen J Forest; Thiru Chinnadurai; Nicolas Mellas; Sabarivinoth Rangasamy; Yu Xia; Shivank Madan; Prakash Acharya; Mohammad Algodi; Snehal R Patel; Julia Shin; Sasa Vukelic; Daniel B Sims; Morayma Reyes Gil; Henny H Billett; Jorge R Kizer; Daniel J Goldstein; Ulrich P Jorde
Journal:  Ann Thorac Surg       Date:  2019-04-10       Impact factor: 4.330

Review 4.  Extracorporeal membrane oxygenation for critically ill adults.

Authors:  Ralph Tramm; Dragan Ilic; Andrew R Davies; Vincent A Pellegrino; Lorena Romero; Carol Hodgson
Journal:  Cochrane Database Syst Rev       Date:  2015-01-22

5.  Duration of ECMO Is an Independent Predictor of Intracranial Hemorrhage Occurring During ECMO Support.

Authors:  Hesham R Omar; Mehdi Mirsaeidi; Devanand Mangar; Enrico M Camporesi
Journal:  ASAIO J       Date:  2016 Sep-Oct       Impact factor: 2.872

6.  Long-Term Cognitive Outcome and Brain Imaging in Adults After Extracorporeal Membrane Oxygenation.

Authors:  Viktor von Bahr; Håkan Kalzén; Jan Hultman; Björn Frenckner; Christin Andersson; Mikael Mosskin; Staffan Eksborg; Bernhard Holzgraefe
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

7.  Fibrinogen Albumin Ratio and Ischemic Stroke During Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Prakash Acharya; William A Jakobleff; Stephen J Forest; Thiru Chinnadurai; Nicolas Mellas; Snehal R Patel; Jorge R Kizer; Henny H Billett; Daniel J Goldstein; Ulrich P Jorde; Omar Saeed
Journal:  ASAIO J       Date:  2020-03       Impact factor: 3.826

8.  Impairment of cerebral autoregulation in pediatric extracorporeal membrane oxygenation associated with neuroimaging abnormalities.

Authors:  Fenghua Tian; Michael Craig Morriss; Lina Chalak; Ramgopal Venkataraman; Chul Ahn; Hanli Liu; Lakshmi Raman
Journal:  Neurophotonics       Date:  2017-08-19       Impact factor: 3.593

9.  Neurologic Complications of Extracorporeal Membrane Oxygenation.

Authors:  Deena M Nasr; Alejandro A Rabinstein
Journal:  J Clin Neurol       Date:  2015-08-21       Impact factor: 3.077

10.  Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation.

Authors:  Cecilia Maria Veraar; Harald Rinösl; Karina Kühn; Keso Skhirtladze-Dworschak; Alessia Felli; Mohamed Mouhieddine; Johannes Menger; Ekaterina Pataraia; Hendrik Jan Ankersmit; Martin Dworschak
Journal:  Crit Care       Date:  2019-12-30       Impact factor: 9.097

View more
  1 in total

1.  Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls.

Authors:  Jakob Matschke; Henri Lahann; Susanne Krasemann; Hermann Altmeppen; Susanne Pfefferle; Giovanna Galliciotti; Antonia Fitzek; Jan-Peter Sperhake; Benjamin Ondruschka; Miriam Busch; Natalie Rotermund; Kristina Schulz; Christian Lohr; Matthias Dottermusch; Markus Glatzel
Journal:  Front Neurol       Date:  2022-06-16       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.